Thrombotic thrombocytopenic purpura, acquired

Active Research Protocols

  1. 11-C-0102 – A Phase I/II Study of TRC105 in Combination with Sorafenib in Hepatocellular Carcinoma (HCC)
NOTE: PDF documents require the free
Adobe Reader.
This page was last updated: January 24, 2014